MoonLake Immunotherapeutics ^Company

MoonLake Immunotherapeutics is a biopharmaceutical company that is in the clinical stage of developing new therapies. They are focused on using Sonelokimab, a new investigational Nanobody\xae, to treat inflammation and improve patient outcomes.